ClinicalTrials.Veeva

Menu

MenB Vaccine: Implementation Via Information, Empowerment and Accessibility (MenBVaccine)

University of Florida logo

University of Florida

Status

Completed

Conditions

Meningococcal Vaccine

Treatments

Other: Awareness
Other: Education
Other: Accessibility
Other: Empowerment

Study type

Interventional

Funder types

Other

Identifiers

NCT02975596
IRB201703013 (Other Identifier)
IRB201601894
27449113 (Other Grant/Funding Number)

Details and patient eligibility

About

As part of an effort to increase MenB vaccine uptake among adolescents and young adults, study teams will conduct qualitative research to maximize the effectiveness of nationally recommended MenB educational materials. In this study, Study Teams will assess local barriers to MenB vaccination by conducting focus groups with parents, students, and health care professionals.

Full description

Participants (parents of 16-23 year old teens and young adults, high school and college students 16-23 years old, and health care professionals for 16-23 year olds) will be asked to share their thoughts on the completeness of nationally recommended and publicly available MenB vaccine educational materials in addressing hesitations to receipt of the MenB vaccine. There is no risk in discussing reactions to educational materials. The biggest risk is disclosure of information provided in the study which will be reactions to health-promotion material.

Enrollment

1,326 patients

Sex

All

Ages

16 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Must be able to provide informed consent or assent

Exclusion criteria

  • Inability to provide informed consent or assent

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,326 participants in 5 patient groups

Youth
Other group
Description:
Youth between the ages beteen ages 13-18 will be offered awareness, education, empowerment and accessibility intervention components.
Treatment:
Other: Empowerment
Other: Awareness
Other: Education
Other: Accessibility
College
Other group
Description:
Age between 18-23 will be offered awareness, education, empowerment and accessibility intervention components.
Treatment:
Other: Empowerment
Other: Awareness
Other: Education
Other: Accessibility
Adult
Other group
Description:
parents of adolescents and young adults will be offered awareness, education, and accessibility intervention components.
Treatment:
Other: Awareness
Other: Education
Other: Accessibility
Parent focus group
No Intervention group
Description:
Parents discussed barriers and reviewed MenB education materials.
Provider focus groups
No Intervention group
Description:
Providers discussed barriers and reviewed MenB education materials.

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems